| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 29, 2004
From the Division of Cardiology (H.K.P., S.W.B., M.Y.P, S.W.K, Y.-H.C., J.E.P.), Division of Pathology (Y.H.K.), and Division of Vascular Surgery (S.K., D.-I.K., Y.W.K., B.B.L.), Samsung Medical Center and Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Seoul, South Korea; College of Pharmacy, Chungbuk National University, Chongju, South Korea (H.S.Y., M.T.); and Department of Biochemistry and Protein Network Research Center, Yonsei University, Seoul, Korea (E.-C.P., J.-B.Y.). * To whom correspondence should be addressed. E-mail: jepark{at}smc.samsung.co.kr.
Background--We intended to identify proteins that are differentially expressed in human atherosclerotic plaques. Methods and Results--Comparative 2-dimensional electrophoretic analysis on carotid atherosclerotic endarterectomy specimens (n=10) revealed that heat shock protein 27 (Hsp27) expression was significantly increased in the nearby normal-appearing area compared with the plaque core area from the same vessel specimen, which was further confirmed by Western blot analysis. The Hsp27 expression in the adjacent normal-appearing vessel areas was much higher than that in nonatherosclerotic reference arteries. The phosphorylation of Hsp27 showed a gradation in the degree of phosphorylation: greatest in the reference arteries, intermediate in the adjacent normal-appearing area, and lowest in plaque core area. Immunohistochemical analysis showed that the phosphorylation of Hsp27 of smooth muscle cells in the carotid endarterectomy specimens was decreased compared with that in the reference artery specimen. The mean plasma level of Hsp27 was significantly higher in patients with acute coronary syndrome (ACS) (n=27; 106.1±74.1 ng/mL) than in the normal reference subjects (n=29; 45.8±29.5 ng/mL; P<0.005). The plasma levels of Hsp27 were significantly correlated with those of heat shock protein 70 (Hsp70) (r=0.422, P<0.0005), with adjustment for ACS/reference status. Conclusions--In the atherosclerotic lesion, Hsp27 expression is increased in the normal-appearing vessel adjacent to atherosclerotic plaque, whereas levels in the plaque itself are significantly decreased. Both plaque and adjacent artery show decreased Hsp27 phosphorylation compared with reference vessel. In ACS, plasma Hsp27 and Hsp70 are increased, and levels of Hsp27 correlate with Hsp70, C-reactive protein, and CD40L levels.
Revised on May 21, 2006
Accepted on June 19, 2006
Expression of Heat Shock Protein 27 in Human Atherosclerotic Plaques and Increased Plasma Level of Heat Shock Protein 27 in Patients With Acute Coronary Syndrome
Haing Kee Park BS,
This article has been cited by other articles:
![]() |
K. Rayner, Y.-X. Chen, M. McNulty, T. Simard, X. Zhao, D. J. Wells, J. de Belleroche, and E. R. O'Brien Extracellular Release of the Atheroprotective Heat Shock Protein 27 Is Mediated by Estrogen and Competitively Inhibits acLDL Binding to Scavenger Receptor-A Circ. Res., July 18, 2008; 103(2): 133 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gruden, G. Bruno, N. Chaturvedi, D. Burt, C. Schalkwijk, S. Pinach, C. D. Stehouwer, D. R. Witte, J. H. Fuller, P. C. Perin, et al. Serum Heat Shock Protein 27 and Diabetes Complications in the EURODIAB Prospective Complications Study: A Novel Circulating Marker for Diabetic Neuropathy Diabetes, July 1, 2008; 57(7): 1966 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-Q. Shen, L. Li, S. Rao, K. G. Abdullah, J. M. Ban, B.-S. Lee, J. E. Park, and Q. K. Wang Four SNPs on Chromosome 9p21 in a South Korean Population Implicate a Genetic Locus That Confers High Cross-Race Risk for Development of Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 360 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kardys, N. Rifai, O. Meilhac, J.-B. Michel, J. L. Martin-Ventura, J. E. Buring, P. Libby, and P. M Ridker Plasma Concentration of Heat Shock Protein 27 and Risk of Cardiovascular Disease: A Prospective, Nested Case-Control Study Clin. Chem., January 1, 2008; 54(1): 139 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. VAN EDEN, G. WICK, S. ALBANI, and I. COHEN Stress, Heat Shock Proteins, and Autoimmunity: How Immune Responses to Heat Shock Proteins Are to Be Used for the Control of Chronic Inflammatory Diseases Ann. N.Y. Acad. Sci., October 1, 2007; 1113(1): 217 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. RIGANỎ, E. PROFUMO, B. BUTTARI, A. TAGLIANI, L. PETRONE, G. D'AMATI, F. IPPOLITI, R. CAPOANO, L. FUMAGALLI, B. SALVATI, et al. Heat Shock Proteins and Autoimmunity in Patients with Carotid Atherosclerosis Ann. N.Y. Acad. Sci., June 1, 2007; 1107(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Rose and M. J. Dunn Letter by Rose and Dunn Regarding Article, "Expression of Heat Shock Protein 27 in Human Atherosclerotic Plaques and Increased Plasma Level of Heat Shock Protein 27 in Patients With Acute Coronary Syndrome" Circulation, May 1, 2007; 115(17): e434 - e434. [Full Text] [PDF] |
||||
![]() |
H. K. Park, S. W. Bae, M. Y. Park, S. W. Kim, Y.-H. Choi, B.-S. Lee, J. E. Park, Y. H. Ko, S. Kim, D.-I. Kim, et al. Response to Letter Regarding Article, "Expression of Heat Shock Protein 27 in Human Atherosclerotic Plaques and Increased Plasma Level of Heat Shock Protein 27 in Patients With Acute Coronary Syndrome" Circulation, May 1, 2007; 115(17): e435 - e435. [Full Text] [PDF] |
||||
![]() |
G. Wick The Heat Is on: Heat-Shock Proteins and Atherosclerosis Circulation, August 29, 2006; 114(9): 870 - 872. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |